Histiocytosis: all 63 studies
Page 1 of 1. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- Biomarkers in Systemic HistiocytosisNot yet recruitingNCT07157683
- Cardiac Imaging in Systemic Disorders: the ORACLES RegistryNot yet recruitingNCT07134166
- Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in ChildrenRecruitingNCT07022834Phase 2
- Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and AdolescentsEnrolling by invitationNCT06902792Phase 1
- Histiocytosis and Inflammatory Manifestations in Patients with H SyndromeRecruitingNCT06742073
- Histiocytosis in Injecting Drug UsersEnrolling by invitationNCT06573671
- Biomarkers for Diagnostic, Prognostic and of Response to Treatment in Adult Langerhans Cell HistiocytosisRecruitingNCT06197204
- Oral Prednisone in Treating LCH of Bone in Childhood and AdolescenceRecruitingNCT06078969Phase 2
- National Registry of Rare Kidney DiseasesRecruitingNCT06065852
- To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCHRecruitingNCT05997602Phase 2
- Histiocytic Disorder Follow-up StudyRecruitingNCT05915208
- Characterizing Histiocytosis With 68Ga-FAPI PET/CTNot yet recruitingNCT05803629Not applicable
- Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesRecruitingNCT05786924Phase 1/2
- Safety and Efficacy of CD207 Targeted CAR-T Cell Therapy in Patients With R/R Langerhans Cell HistiocytosisNot yet recruitingNCT05477446Phase 1
- A Prospective Study for the Treatment of Children With Newly Diagnosed LCH Using a Cytarabine Contained ProtocolRecruitingNCT04773366Phase 3
- Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort StudyRecruitingNCT04665674
- LCH in Adults: a Collaborative, Prospective-retrospective, Observational StudyRecruitingNCT04627090
- Molecular Targets for the Treatment of HistiocytosisRecruitingNCT04437381
- Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)CompletedNCT03233204Phase 2Results posted
- Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)CompletedNCT03220035Phase 2Results posted
- Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaCompletedNCT03096782Phase 2Results posted
- Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell HistiocytosisCompletedNCT03052101Results posted
- Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesCompletedNCT01273766Phase 2Results posted
- Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell HistiocytosisTerminatedNCT00618540Phase 2Results posted
- Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCHCompletedNCT00588536Phase 2Results posted
- Stem Cell Transplant for Immunologic or Histiocytic DisordersCompletedNCT00176865Phase 2Results posted
- T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic DisordersTerminatedNCT00176826Phase 2/3Results posted
- HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic MalignanciesCompletedNCT00145626Phase 2Results posted
- Central China Rosai-Dorfman Disease RegistryStatus unknownNCT05284942Phase 4
- Prevalence of Mood and Anxiety Disorders in Adult Patients With Pulmonary Langerhans Cell HistiocytosisStatus unknownNCT05114304
- The Efficacy and Safety of HLX208 in Adult Langerhans Cell Histiocytosis (LCH) and Erdheim-Chester Disease (ECD) With BRAF V600E MutationActive, not recruitingNCT05092815Phase 2
- Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile PatientsActive, not recruitingNCT04943224Phase 2
- Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT ImagingActive, not recruitingNCT04943211Phase 3
- Optimization of the Time and Dosage of Vemurafenib in BRAF Positive Juvenile Patients With Refractory HistiocytosisActive, not recruitingNCT04943198Phase 2
- AraC for Newly Diagnosed Adult Langerhans Cell HistiocytosisStatus unknownNCT04121819Phase 2
- Thalidomide, Cyclophosphamide and Dexamethasone for Recurrent/Refractory Adult Langerhans Cell HistiocytosisStatus unknownNCT04120519Phase 2
- Cobimetinib for BRAF-wild-type or Mutated HistiocytosesCompletedNCT04007848Phase 3
- A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E MutationStatus unknownNCT03585686Phase 2
- Denosumab for the Treatment of Adult LCHCompletedNCT03270020Phase 2
- A Study of Memory, Thinking, and Brain Imaging in Adults With HistiocytosisActive, not recruitingNCT03127709
- Characterization of Pulmonary Langerhans Cell HistiocytosisStatus unknownNCT03093727
- Search Elevated Serum Alkaline Phosphatase as a Marker of Prenatal Intervillositis Chronic HistiocyticCompletedNCT02668120
- Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell HistiocytosisCompletedNCT02665546
- Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy MeasurementCompletedNCT02608619
- Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.TerminatedNCT02012231Phase 1
- CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell TransplantationActive, not recruitingNCT01966367Phase 1/2
- Clofarabine for Langerhans in PediWithdrawnNCT01796405Phase 2
- Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung FunctionCompletedNCT01651507
- Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell HistiocytosisStatus unknownNCT01473797Phase 2
- A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell HistiocytosisCompletedNCT01395004Phase 2
- Ceftriaxone in Non-neutropenic FeverCompletedNCT01225718
- Prospective Evaluation of Adult Pulmonary Langerhans Cell HistiocytosisCompletedNCT01225601
- Unrelated Donor Transplant for Malignant and Non-Malignant DisordersTerminatedNCT01050439Phase 2
- CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor TransplantCompletedNCT01049854Phase 2
- Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
- H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell HistiocytosisWithdrawnNCT00488605Phase 3
- Cardiovascular Risk Factors and LCH in AdultsStatus unknownNCT00483925
- Combination Chemotherapy in Treating Young Patients With Langerhans Cell HistiocytosisCompletedNCT00276757Not applicable
- Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant DiseasesStatus unknownNCT00084695Phase 2
- Treatment of Resistant Langerhans Cell Histiocytosis With ENBRELCompletedNCT00048373Phase 2
- Blood Stem Cell Transplant in Treating Patients With Hematologic CancerTerminatedNCT00008216
- Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic AnemiaStatus unknownNCT00008164Phase 2
- Indium In 111 Pentetreotide in Treating Patients With Refractory CancerTerminatedNCT00002947Phase 1